Cargando…

Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer

PURPOSE: High-performing imaging and predictive markers are warranted to minimize surgical overtreatment of the axilla in breast cancer (BC) patients receiving neoadjuvant chemotherapy (NACT). Here we have investigated whether axillary ultrasound (AUS) could identify axillary lymph node (ALN) metast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skarping, Ida, Förnvik, Daniel, Zackrisson, Sophia, Borgquist, Signe, Rydén, Lisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302508/ https://www.ncbi.nlm.nih.gov/pubmed/34120224 http://dx.doi.org/10.1007/s10549-021-06283-8

Ejemplares similares

Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer
por: Skarping, Ida, et al.
Publicado: (2019)

Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients
por: Skarping, Ida, et al.
Publicado: (2020)

Mammographic density changes during neoadjuvant breast cancer treatment: NeoDense, a prospective study in Sweden
por: Skarping, Ida, et al.
Publicado: (2020)

The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer
por: Skarping, Ida, et al.
Publicado: (2022)

Does shear wave ultrasound independently predict axillary lymph node metastasis in women with invasive breast cancer?
por: Evans, Andrew, et al.
Publicado: (2013)

Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure
por: Verheuvel, Nicole C., et al.
Publicado: (2017)

Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment
por: Förnvik, Daniel, et al.
Publicado: (2019)

Systematic versus sentinel-lymph-node-driven axillary-lymph-node dissection in clinically node-negative patients with operable breast cancer. Results of the GF-GS01 randomized trial
por: Roy, P., et al.
Publicado: (2018)

Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer
por: Zetterlund, Linda Holmstrand, et al.
Publicado: (2017)

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
por: Choi, Hee Jun, et al.
Publicado: (2022)

The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer
por: de Boniface, Jana, et al.
Publicado: (2020)

Noninvasive Staging of Lymph Node Status in Breast Cancer Using Machine Learning: External Validation and Further Model Development
por: Hjärtström, Malin, et al.
Publicado: (2023)

Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA study
por: Hartmann, Steffi, et al.
Publicado: (2023)

Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment
por: Tinterri, Corrado, et al.
Publicado: (2023)

Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer
por: Zetterlund, Linda, et al.
Publicado: (2017)

False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy
por: de Boniface, Jana, et al.
Publicado: (2022)

De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study
por: Simons, J. M., et al.
Publicado: (2020)

Impact of analysis of the sentinel lymph node by one-step nucleic acid amplification (OSNA) compared to conventional histopathology on axillary and systemic treatment: data from the Dutch nationwide cohort of breast cancer patients
por: van Haaren, Elisabeth R. M., et al.
Publicado: (2023)

Analysis of mammograms using artificial intelligence to predict response to neoadjuvant chemotherapy in breast cancer patients: proof of concept
por: Skarping, I., et al.
Publicado: (2021)

Sentinel Lymph Node Biopsy in Breast Cancer Patients With Pathological Complete Response in the Axillary Lymph Node After Neoadjuvant Chemotherapy
por: Kim, Hyunhee, et al.
Publicado: (2021)

The implementation of NILS: A web-based artificial neural network decision support tool for noninvasive lymph node staging in breast cancer
por: Dihge, Looket, et al.
Publicado: (2023)

Nomogram for predicting axillary lymph node status after neoadjuvant chemotherapy in breast cancer
por: Wang, Mengshen, et al.
Publicado: (2020)

Sentinel lymph node biopsy of the internal mammary chain in breast cancer
por: Postma, E. L., et al.
Publicado: (2012)

39607 Mapping the Draining Lymph Nodes in Central Nervous System Malignancies
por: Coxon, Andrew T., et al.
Publicado: (2021)

Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe?
por: Qu, Fei-Lin, et al.
Publicado: (2022)

Higher Pathological Complete Response Rate of Less than 10 Total Axillary Lymph Nodes After Axillary Lymph Node Dissection Following Neoadjuvant Chemotherapy in Breast Cancer
por: Lee, Jeeyeon, et al.
Publicado: (2022)

Nomogram for predicting axillary lymph node pathological response in node-positive breast cancer patients after neoadjuvant chemotherapy
por: Wang, Wenyan, et al.
Publicado: (2022)

Effects of statin use on volumetric mammographic density: results from the KARMA study
por: Skarping, Ida, et al.
Publicado: (2015)

Targeted axillary biopsy and sentinel lymph node biopsy for axillary restaging after neoadjuvant chemotherapy
por: Gurleyik, Gunay, et al.
Publicado: (2021)

Factors Associated with Axillary Lymph Node Status in Clinically Node-Negative Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
por: Yu, Chi-Chang, et al.
Publicado: (2022)

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy
por: van Roozendaal, L. M., et al.
Publicado: (2016)

Factors affecting the number of sentinel lymph nodes removed in patients having surgery for breast cancer
por: Dixon, J. Michael, et al.
Publicado: (2020)

Combination of pegylated liposomal doxorubicin and docetaxel as neoadjuvant therapy for breast cancer with axillary lymph node metastasis
por: Wang, Li, et al.
Publicado: (2020)

Whole sentinel lymph node analysis by a molecular assay predicts axillary node status in breast cancer
por: Ohi, Y, et al.
Publicado: (2012)

Absence of post-treatment changes in sentinel lymph nodes does not translate into increased regional recurrence rate in initially node-positive breast cancer patients
por: Pislar, Nina, et al.
Publicado: (2023)

Nomograms for Predicting Axillary Lymph Node Status Reconciled With Preoperative Breast Ultrasound Images
por: Liu, Dongmei, et al.
Publicado: (2021)

Options to Determine Pathological Response of Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Advanced Breast Cancer
por: Murthy, Vijayashree, et al.
Publicado: (2021)

Prediction of axillary lymph node pathological complete response to neoadjuvant therapy using nomogram and machine learning methods
por: Zhou, Tianyang, et al.
Publicado: (2022)

Prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor
por: Wu, Jia-Long, et al.
Publicado: (2014)

The NILS Study Protocol: A Retrospective Validation Study of an Artificial Neural Network Based Preoperative Decision-Making Tool for Noninvasive Lymph Node Staging in Women with Primary Breast Cancer (ISRCTN14341750)
por: Skarping, Ida, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_grctk2gcvalc8f6a8ub7mfnicc